These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8488915)
1. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Lesk MR; Ammann H; Marcil G; Vinet B; Lamer L; Sebag M Am J Ophthalmol; 1993 May; 115(5):623-8. PubMed ID: 8488915 [TBL] [Abstract][Full Text] [Related]
2. Vitreous penetration of orally administered gatifloxacin in humans. Hariprasad SM; Mieler WF; Holz ER Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689 [TBL] [Abstract][Full Text] [Related]
3. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Hariprasad SM; Mieler WF; Holz ER Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704 [TBL] [Abstract][Full Text] [Related]
4. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous. Yalvac IS; Basci NE; Bozkurt A; Duman S J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011 [TBL] [Abstract][Full Text] [Related]
5. Aqueous and vitreous penetration of levofloxacin after oral administration. Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658 [TBL] [Abstract][Full Text] [Related]
6. Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes. Oztürk F; Kortunay S; Kurt E; Ilker SS; Basci NE; Bozkurt A Retina; 1999; 19(3):218-22. PubMed ID: 10380027 [TBL] [Abstract][Full Text] [Related]
7. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration. Cekiç O; Batman C; Yasar U; Başci NE; Bozkurt A; Kayaalp SO Eye (Lond); 1999 Aug; 13 ( Pt 4)():555-8. PubMed ID: 10692930 [TBL] [Abstract][Full Text] [Related]
8. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans. Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948 [TBL] [Abstract][Full Text] [Related]
9. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810 [TBL] [Abstract][Full Text] [Related]
10. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes. Beck R; van Keyserlingk J; Fischer U; Guthoff R; Drewelow B Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):89-92. PubMed ID: 9987622 [TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery. Yu-Speight AW; Kern TJ; Erb HN Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371 [TBL] [Abstract][Full Text] [Related]
12. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819 [TBL] [Abstract][Full Text] [Related]
13. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops. Cekiç O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO Can J Ophthalmol; 1998 Dec; 33(7):373-6. PubMed ID: 9885752 [TBL] [Abstract][Full Text] [Related]
14. [Intraocular penetration of ciprofloxacin after infusion and oral administration]. Mounier M; Adenis JP; Denis F Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):724-7. PubMed ID: 3054755 [TBL] [Abstract][Full Text] [Related]
15. The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin. Oztürk F; Kurt E; Inan UU; Kortunay S; Ilker SS; Başci NE; Bozkurt A Int J Pharm; 2000 Aug; 204(1-2):97-100. PubMed ID: 11011991 [TBL] [Abstract][Full Text] [Related]
16. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293 [TBL] [Abstract][Full Text] [Related]
17. The ocular penetration of oral sparfloxacin in humans. Bron AM; Pechinot AP; Garcher CP; Guyonnet GA; Kazmierczak AM; Schott DA; Lecoeur H Am J Ophthalmol; 1994 Mar; 117(3):322-7. PubMed ID: 8129004 [TBL] [Abstract][Full Text] [Related]
18. Penetration of oral and topical ciprofloxacin into human aqueous humor. Celebi S; Ay S; Aykan U; Bulut V; Alagöz G; Celiker UO Acta Ophthalmol Scand; 1998 Dec; 76(6):683-5. PubMed ID: 9881552 [TBL] [Abstract][Full Text] [Related]
19. Penetration of imipenem into human aqueous and vitreous humor. Axelrod JL; Newton JC; Klein RM; Bergen RL; Sheikh MZ Am J Ophthalmol; 1987 Dec; 104(6):649-53. PubMed ID: 3500645 [TBL] [Abstract][Full Text] [Related]
20. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration. Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]